Healthcare Healthcare

Stifel ranks among top investment banks in U.K. capital raising market

Stifel Europe News

Grow your small or mid cap company with Stifel Europe’s Healthcare Team

Stifel’s European Healthcare Team provides capital markets and advisory services on a pan-European and global basis across the full range of healthcare companies, from biotech, medtech, and diagnostics to animal health, OTC, and specialty pharma as well as outsourced pharma services and healthcare services.

We provide a full-service product offering to clients including M&A (both company and asset based), equity capital raising (including both IPOs and follow-on offerings), corporate broking services for listed companies, and capital solutions. We have particular expertise in helping European biotechnology companies access the U.S. capital markets. We have served as bookrunner on three of the UK/European healthcare company dual listings on Nasdaq in 2020 year to date and are a leading global franchise in branded healthcare products, such as animal health and OTC/consumer health.

The team’s success has been built on its deep industry and scientific knowledge, exceptional access to investors, and global connectivity in our core segments, which allows our team to offer a comprehensive and integrated approach to addressing clients’ needs in the most effective way. We also work closely with our U.S. banking partners, offering a highly differentiated proposition for UK and European companies raising capital in the U.S.

Meet Our Team

Brad Raymond
Charles Hoare

Managing Director
Healthcare M&A

Brad Raymond
Nicholas Moore

Managing Director
Healthcare ECM

Brad Raymond
Irina Konovalova

Director
Healthcare

Brad Raymond
Ben Maddison

Director
Healthcare

Recent Transactions

Dollar volume represents full credit to each underwriter. All transaction announcements appear as a matter of record only. Stifel collectively refers to Stifel, Nicolaus & Company, Incorporated and other affiliated broker-dealer subsidiaries of Stifel Financial Corp. Unless otherwise indicated, information presented herein with respect to the experience of Stifel also includes transactions effected and matters conducted by companies acquired by Stifel (including pending acquisitions publicly announced by Stifel).

Contact Our London Office

50+

Healthcare Transactions Announced Globally Since March 2020


We Ranked

#1

in Equity Deals Under $1 Billion Market Cap

Source: Dealogic. Rank-eligible SEC registered IPOs and follow-on offerings since 2010 as of 31/01/20


#1

Among Middle-Market Firms in M&A Transactions Under $1 Billion

Source: M&A Analytics as of 31/01/20


#3

in All Managed Venture Capital-Backed IPOs

Source: Dealogic. Venture-backed IPOs ranking since 2005 as of 31/12/19. (8) M&A Analytics as of 31/01/20